United States · Research startup

A2 Biotherapeutics, Inc.

A2 Biotherapeutics, Inc.

Funding reportedLast round: Series B

ResearchAgoura Hills, United States

About A2 Biotherapeutics, Inc.

A2 Biotherapeutics, Inc.

is a clinical-stage biotechnology company based in Agoura Hills, California, founded in 2018. The company is focused on developing precision CAR T-cell therapies for solid tumors using its proprietary TmodTM cell engineering platform. This innovative technology enables T cells to selectively target tumor cells while sparing normal cells, addressing a significant challenge in cancer treatment. The company is advancing a pipeline of first-in-class logic-gated cell therapies aimed at treating various solid tumors, including pancreatic, lung, colorectal, ovarian, and mesothelioma cancers. A2 Biotherapeutics operates within the oncology sector, serving cancer patients globally through a business-to-business model that delivers its therapies via healthcare systems and oncology clinics. With a strong foundation in both autologous and allogeneic applications, A2 Biotherapeutics is committed to restoring health and hope for individuals living with cancer and other serious diseases.

What company datasets say A2 Biotherapeutics, Inc. raised

Funding, as reported

Reported in all$191Min dollars
Rounds4
Last roundSeries B
Last round size$80M
Last round dateDec 2022
Investors listed8

Founders and team

From A2 Biotherapeutics, Inc.'s own website: 4 on the team.

  • James RobinsonPresident & Chief Executive Officer
  • Thomas LeungChief Financial Officer
  • Vikram JoshiChief Business Officer
  • Ryan CardGeneral Counsel

On a portfolio page

Investors who name them

Each firm lists A2 Biotherapeutics, Inc. on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

The company, in detail

What they build

Known for

research infrastructurehospital & health careresearchbiological pathwayshealth caretumor microenvironmenttumor immunologycompanion diagnosticoncologycellular immunotherapyresearch and developmenttargeting tumor microenvironmentinnovative therapiesallogeneic cell therapycancer immunologycgmp manufacturing

Built with from their website

YoastYoast SEOGoogle MapsCookieYesKnowBe4123ContactFormAmazon SESWP RocketMicrosoft Email ProvidersCloudFlare CDN

+8 more

Google Tag Manager123FormBuilderHTTP/3Cloudflare Rocket LoaderGoogle Maps (Non Paid Users)Amazon Simple Email ServiceOWL CarouselBootstrap

Sector
Research
Industry code
NAICS 541714, SIC 2834, 8731
Region
California
Revenue
$33M a year, as listed
Full record
Every detail in the company directory

Research in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put A2 Biotherapeutics, Inc. in front of investors. Or tell us what we have wrong.